# The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib

> **NCT06912659** · — · ACTIVE_NOT_RECRUITING · sponsor: **Boehringer Ingelheim** · enrollment: 157 (actual)

## Conditions studied

- Pulmonary Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06912659
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-06-23
- **Primary completion:** 2026-12-23
- **Final completion:** 2026-12-23
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06912659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06912659, "The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06912659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*